Untangling the roles of antidepressants and mood stabilizers in the treatment of Alzheimer's disease. Introduction.
Reiman
Eric M
EM
ereiman@psychiatrist.com
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007508:Irritable Mood / Q000187:drug effects; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D009042:Motivation; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D016651:Lithium Carbonate; D017367:Selective Serotonin Reuptake Inhibitors